These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16030156)

  • 1. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects.
    Tao YX; Segaloff DL
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5632-8. PubMed ID: 16030156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating.
    Lubrano-Berthelier C; Dubern B; Lacorte JM; Picard F; Shapiro A; Zhang S; Bertrais S; Hercberg S; Basdevant A; Clement K; Vaisse C
    J Clin Endocrinol Metab; 2006 May; 91(5):1811-8. PubMed ID: 16507637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations.
    Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF
    N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review.
    Valette M; Bellisle F; Carette C; Poitou C; Dubern B; Paradis G; Hercberg S; Muzard L; Clément K; Czernichow S
    Int J Obes (Lond); 2013 Aug; 37(8):1027-35. PubMed ID: 23147118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
    Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
    Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population.
    Rong R; Tao YX; Cheung BM; Xu A; Cheung GC; Lam KS
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):198-205. PubMed ID: 16886960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany.
    Hinney A; Bettecken T; Tarnow P; Brumm H; Reichwald K; Lichtner P; Scherag A; Nguyen TT; Schlumberger P; Rief W; Vollmert C; Illig T; Wichmann HE; Schäfer H; Platzer M; Biebermann H; Meitinger T; Hebebrand J
    J Clin Endocrinol Metab; 2006 May; 91(5):1761-9. PubMed ID: 16492696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity.
    Tao YX; Segaloff DL
    Endocrinology; 2003 Oct; 144(10):4544-51. PubMed ID: 12959994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations.
    Hebebrand J; Geller F; Dempfle A; Heinzel-Gutenbrunner M; Raab M; Gerber G; Wermter AK; Horro FF; Blundell J; Schäfer H; Remschmidt H; Herpertz S; Hinney A
    Mol Psychiatry; 2004 Aug; 9(8):796-800. PubMed ID: 15037865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocortin-4 receptor gene variants are not associated with binge-eating behavior in nonobese patients with eating disorders.
    Gamero-Villarroel C; Rodriguez-Lopez R; Jimenez M; Carrillo JA; Garcia-Herraiz A; Albuquerque D; Flores I; Gervasini G
    Psychiatr Genet; 2015 Feb; 25(1):35-8. PubMed ID: 25419636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.
    Rettenbacher E; Tarnow P; Brumm H; Prayer D; Wermter AK; Hebebrand J; Biebermann H; Hinney A; Widhalm K
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):7-12. PubMed ID: 17286227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.
    Wang XH; Wang HM; Zhao BL; Yu P; Fan ZC
    J Mol Endocrinol; 2014 Aug; 53(1):17-29. PubMed ID: 24780838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and functional relevance of melanocortin-4 receptor variants in obese German children.
    Melchior C; Schulz A; Windholz J; Kiess W; Schöneberg T; Körner A
    Horm Res Paediatr; 2012; 78(4):237-46. PubMed ID: 23146882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis.
    Hainerová I; Larsen LH; Holst B; Finková M; Hainer V; Lebl J; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3689-96. PubMed ID: 17579204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic analyses of four chicken melanocortin-4 receptor mutations.
    Wang ZQ; Huang JS; Zhou JH; Shi L; Jiang XF; Tao YX
    Domest Anim Endocrinol; 2016 Jan; 54():68-75. PubMed ID: 26521202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population.
    Ochoa MC; Azcona C; Biebermann H; Brumm H; Razquin C; Wermter AK; Martínez JA; Hebebrand J; Hinney A; Moreno-Aliaga MJ; Marti A; Patiño A; Chueca M; Oyarzabal M; Pelach R;
    Clin Endocrinol (Oxf); 2007 May; 66(5):652-8. PubMed ID: 17492953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G modulation of the melanocortin 4 receptor signaling in obesity and eating disorders.
    Lucas N; Legrand R; Bôle-Feysot C; Breton J; Coëffier M; Akkermann K; Järv A; Harro J; Déchelotte P; Fetissov SO
    Transl Psychiatry; 2019 Feb; 9(1):87. PubMed ID: 30755592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
    Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
    J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese finnish children and adults.
    Valli-Jaakola K; Lipsanen-Nyman M; Oksanen L; Hollenberg AN; Kontula K; Bjørbaek C; Schalin-Jäntti C
    J Clin Endocrinol Metab; 2004 Feb; 89(2):940-5. PubMed ID: 14764818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel melanocortin 4 receptor gene mutations in severely obese children.
    Lee YS; Poh LK; Kek BL; Loke KY
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):529-35. PubMed ID: 17941900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.